Evidence map›Paper›PMID 34667719›Full record

ArticleMolecular genetics and metabolism reports2021

Valine metabolites analysis in ECHS1 deficiency.

Mari Kuwajima, Karin Kojima, Hitoshi Osaka, Yusuke Hamada, Eriko Jimbo, Miyuki Watanabe, Shiho Aoki, Ikuko Sato-Shirai, Keiko Ichimoto, Takuya Fushimi and 13 more

Open access · goldAbstract read
In one paragraph

Article in Molecular genetics and metabolism reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Total and reduced/oxidized forms of coenzyme QMolecular genetics and metabolism reports · 2023
    Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 10 institutions in 1 country.

Mari KuwajimaDepartment of Pediatrics, Jichi Medical University, Tochigi, Japan.
Karin KojimaDepartment of Pediatrics, Jichi Medical University, Tochigi, Japan.
Hitoshi OsakaDepartment of Pediatrics, Jichi Medical University, Tochigi, Japan.
Yusuke HamadaDepartment of Pediatrics, Toyonaka Municipal Hospital, Osaka, Japan.
Eriko JimboDepartment of Pediatrics, Jichi Medical University, Tochigi, Japan.
Miyuki WatanabeDepartment of Pediatrics, Jichi Medical University, Tochigi, Japan.
Shiho AokiDepartment of Pediatrics, Jichi Medical University, Tochigi, Japan.
Ikuko Sato-ShiraiDepartment of Pediatrics, Tokyo Metropolitan Fuchu Ryoiku Center, Tokyo, Japan.
Keiko IchimotoDepartment of Metabolism, Chiba Children's Hospital, Chiba, Japan.
Takuya FushimiDepartment of Metabolism, Chiba Children's Hospital, Chiba, Japan.
Kei MurayamaDepartment of Metabolism, Chiba Children's Hospital, Chiba, Japan.
Akira OhtakeDepartment of Pediatrics & Clinical Genomics, Faculty of Medicine, Saitama Medical University, Saitama, Japan.
Masakazu KohdaDiagnostics and Therapeutics of Intractable Diseases, Intractable Disease Research Center, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
Yoshihito KishitaDiagnostics and Therapeutics of Intractable Diseases, Intractable Disease Research Center, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
Yukiko YatsukaDiagnostics and Therapeutics of Intractable Diseases, Intractable Disease Research Center, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
Shumpei UchinoDepartment of Pediatrics, Teikyo University School of Medicine, Tokyo, Japan.
Masakazu MimakiDepartment of Pediatrics, Teikyo University School of Medicine, Tokyo, Japan.
Noriko MiyakeDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Naomichi MatsumotoDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Yasushi OkazakiDiagnostics and Therapeutics of Intractable Diseases, Intractable Disease Research Center, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
Tomomi OgataDepartment of Pediatrics, Gunma University Graduate School of medicine, Maebashi, Japan.
Takanori YamagataDepartment of Pediatrics, Jichi Medical University, Tochigi, Japan.
Kazuhiro MuramatsuDepartment of Pediatrics, Jichi Medical University, Tochigi, Japan.
Jichi Medical University · JPJuntendo University · JPChiba Hospital · JPTeikyo University · JPNational Center for Global Health and Medicine · JPRIKEN Center for Integrative Medical Sciences · JPSaitama Medical University Hospital · JPTobu Ryoiku Center · JPToyonaka Municipal Hospital · JPYokohama City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Short-chain enoyl-CoA hydratase (ECHS1) is involved in amino acid and fatty acid catabolism in mitochondria and its deficiency causes Leigh syndrome or exercise-induced dystonia. More than 60 patients with this condition have been reported till date. The accumulation of intermediate metabolites of valine is assumed to be responsible for the cytotoxicity. Since protein restriction, including valine reportedly improves neurological symptoms, it is essential to consider the possible incidence of and diagnose ECHS1 syndrome in the earlier stages. This study reported the liquid chromatography with tandem mass spectrometry (LC-MS/MS) urine and plasma metabolite analysis in six cases, including four new cases with ECHS1 deficiency. The values of urine cysteine/cysteamine conjugates from valine metabolites, S-(2-carboxypropyl) cysteine/cysteamine from methacrylyl-CoA, and S-(2-carboxyethyl) cysteine/cysteamine from acryloyl-CoA were separated between six patients and six normal controls. The LC-MS/MS analysis revealed that these metabolites can be used for the early diagnosis and evaluation of diet therapy.

Indexed as

Diet therapyECHS1, short-chain enoyl-CoA hydrataseLC-MS/MS, liquid chromatography with tandem mass spectrometryLeigh syndromeSCECM, S-(2-carboxyethyl)cysteamineSCEC, S-(2-carboxyethyl)cysteineSCPCM, S-(2-carboxypropyl) cysteamineSCPC, S-(2-carboxypropyl) cysteineShort-chain enoyl-CoA hydratase deficiency

Identifiers

PMID34667719
PMCPMC8507190
OpenAlexW3206667607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.